One-on-one consultation Your provider discusses your goals, nutrition, hydration, protein intake, and what the first few weeks look like
J Biol Chem 264(22):1282612829
For patients primarily struggling with appetite control and food cravings, GLP-1 medications might be more beneficial
A Phase 2a multicenter, single-arm, open-label study (NCT03695185) enrolled 42 participants with moderate to severe UC who had failed prior biologic therapies, administering ravagalimab 600 mg IV at week 0 followed by 300 mg subcutaneous doses at weeks 2, 4, 6, 8, and 10
Watch for Red Flags: Fatigue, mood changes, palpitations, or new weight swings could signal an imbalance